MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Predicting Longitudinal Atrophy in Parkinson’s Disease using SIR model

    A. Abdelgawad, S. Rahayel, C. Tremblay, A. Vo, Y.Q Zheng, R. Markello, B. Misic, A. Dagher (Montreal, QC, Canada)

    Objective: To predict longitudinal brain changes in Parkinson's disease (PD) using an agent-based model. Background: Considerable evidence suggests that α-synuclein(α-syn) behaves in a prion-like fashion,…
  • MDS Virtual Congress 2020

    An overview of vestibular function in Parkinson’s disease

    K. Hawkins, S. Paul, E. Chiarovano, I. Curthoys (Sydney, Australia)

    Objective: To determine if people with Parkinson’s disease (PD) have greater vestibular dysfunction than age-matched healthy people (HC). Background: The vestibular system is crucial for…
  • MDS Virtual Congress 2020

    Analysis of pupillometer results according to motor symptoms severity in Parkinson’s disease patients

    S. You, J. Yoo (Daegu, Republic of Korea)

    Objective: To investigate the value of pupillometric parameters according to the progress of Parkinson’s disease (PD). Background: Pupil light reflex is known to be associated…
  • MDS Virtual Congress 2020

    Quantitative Autonomic Testing in Parkinson’s Disease

    S.M Cheon, G.B Lee, J.W Kim (Busan, Republic of Korea)

    Objective: This study was done to find the clinical correlates with quantitative autonomic testing in Parkinson's disease. Background: Autonomic dysfunction is common and causes variety…
  • MDS Virtual Congress 2020

    Sex-associated difference in the presentation and progression of Parkinson’s disease

    H. Iwaki, C. Blauwendraat, M. Nalls, A. Singleton (Glen Echo, MD, USA)

    Objective: Identifying the contribution of sex to the heterogeneity in presentation and progression of Parkinson’s disease (PD). Background: The different prevalence of Parkinson’s disease (PD)…
  • MDS Virtual Congress 2020

    Orthostatic hypotension in early onset Parkinson’s disease

    Z. Liu, D.N Su, J.H Zhou, T. Feng (Beijing, China)

    Objective: To investigate Orthostatic hypotension (OH)  feature in early onset Parkinson's disease (EOPD)  , especially delayed OH and acute OH post drug.  To explore OH…
  • MDS Virtual Congress 2020

    The effect of exercise on pain in Parkinson’s disease: A protocol for a systematic review

    V. Nguy, L. Hassett, C. Canning, J. Elliott, N. Allen (Sydney, Australia)

    Objective: To perform and present a systematic review assessing the effects of exercise on pain in people with Parkinson’s disease (PD) (prospero registration CRD42019129154). Background:…
  • MDS Virtual Congress 2020

    Association between essential tremor, constipation, and the risk of developing Parkinson’s disease

    C. Reynolds, M. Gupta, M. Sandulescu (Danville, PA, USA)

    Objective: To evaluate the association between constipation and the risk of Parkinson’s disease (PD) in patients with a prior history of essential tremor (ET). Background:…
  • MDS Virtual Congress 2020

    Odor Identification as a Biomarker of Incident Cognitive Impairment and its Correlation with Neuropathology in the Rush MAP

    J. Toledo, J. Schneider, L. Chanine, S. Nag, R. Akhtar, A. Buchman, J. Trojanowski, D. Bennett (Houston, TX, USA)

    Objective: Evaluate the neuropathological correlates and prospective incident cognitive and motor changes associated with odor identification (OI) in cognitively normal (CN) subjects. Background: Hyposmia is…
  • MDS Virtual Congress 2020

    Disease progression characterized by motor performance, dopaminergic neurodegeneration and T cell infiltration in the transgenic hm2-α-SYN-39 mouse model of Parkinson´s disease

    J. Behnke, L. Rauschenberger, S. Knorr, J. Volkmann, C.W Ip (Wuerzburg, Germany)

    Objective: To study disease progression in the transgenic (tg) hm2-α-SYN-39 mouse model of Parkinson´s disease (PD) by assessment of motor performance, dopaminergic neurodegeneration and T…
  • « Previous Page
  • 1
  • …
  • 124
  • 125
  • 126
  • 127
  • 128
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley